Skip to main content
. 2016 Aug 10;49(2):446–453. doi: 10.4143/crt.2016.211

Fig. 1.

Fig. 1.

(A) Event-free survival (EFS) of the ETV6/RUNX1 (+) acute lymphoblastic leukemia (ALL) cohort. (B) EFS of the ETV6/RUNX1 (+) ALL cohort according to overall risk group.